Molecular Blood Test Diagnoses Herpes Simplex Virus Infection
|
By LabMedica International staff writers Posted on 07 Nov 2012 |
Polymerase chain reaction (PCR) is now the test of choice for identifying central nervous system infection caused by herpes simplex virus (HSV).
A longitudinal review of HSV PCR testing at two pediatric academic medical centers in the USA determined the clinical features of children positive for serum HSV through PCR testing.
Scientists at the University of Texas Southwestern Medical Center (Dallas, TX, USA) in collaboration with others carried out a retrospective review of all patients who had a serum HSV PCR test at the participating institutions from 2005 to 2010. The study focused on children with one positive blood HSV PCR test and reviewed their charts for demographic, clinical, and other data. They defined a neonatal HSV infection as occurring before 42 days of age.
More than 700 patients received blood HSV PCR testing during the study period. Of those children, 294 were infants younger than 42 days old. A positive HSV PCR test was found in 45 patients (6.1%), 21 of whom were infants. Of these infants, approximately 25% were diagnosed with skin, eye, and mouth HSV disease; another 25% were diagnosed with central nervous system HSV disease; and approximately 50% had disseminated HSV disease. One third of the neonatal HSV patients in this study died. For two of those infants, the blood HSV PCR was the only positive HSV test. In another four children, the blood HSV PCR was the first test that was positive.
Among the 24 older children with positive blood HSV PCR tests, 50% were immunocompromised. Another 29% suffered from atopic dermatitis. Mucocutaneous lesions were much more common, occurring in 92% of these older children and 13% of the older children died. In four of the older children, the blood HSV PCR was the only positive test, and it was the first positive test in another seven of these children, all of whom had vesicular lesions that would have clinically suggested an HSV diagnosis. The authors concluded that HSV PCR testing on serum samples can be a useful adjunct in the diagnosis of HSV, especially among young infants who are much less likely than older children to have mucocutaneous lesions. The study was published in the August 2012 edition of the Journal of Pediatrics.
Related Links:
University of Texas Southwestern Medical Center
A longitudinal review of HSV PCR testing at two pediatric academic medical centers in the USA determined the clinical features of children positive for serum HSV through PCR testing.
Scientists at the University of Texas Southwestern Medical Center (Dallas, TX, USA) in collaboration with others carried out a retrospective review of all patients who had a serum HSV PCR test at the participating institutions from 2005 to 2010. The study focused on children with one positive blood HSV PCR test and reviewed their charts for demographic, clinical, and other data. They defined a neonatal HSV infection as occurring before 42 days of age.
More than 700 patients received blood HSV PCR testing during the study period. Of those children, 294 were infants younger than 42 days old. A positive HSV PCR test was found in 45 patients (6.1%), 21 of whom were infants. Of these infants, approximately 25% were diagnosed with skin, eye, and mouth HSV disease; another 25% were diagnosed with central nervous system HSV disease; and approximately 50% had disseminated HSV disease. One third of the neonatal HSV patients in this study died. For two of those infants, the blood HSV PCR was the only positive HSV test. In another four children, the blood HSV PCR was the first test that was positive.
Among the 24 older children with positive blood HSV PCR tests, 50% were immunocompromised. Another 29% suffered from atopic dermatitis. Mucocutaneous lesions were much more common, occurring in 92% of these older children and 13% of the older children died. In four of the older children, the blood HSV PCR was the only positive test, and it was the first positive test in another seven of these children, all of whom had vesicular lesions that would have clinically suggested an HSV diagnosis. The authors concluded that HSV PCR testing on serum samples can be a useful adjunct in the diagnosis of HSV, especially among young infants who are much less likely than older children to have mucocutaneous lesions. The study was published in the August 2012 edition of the Journal of Pediatrics.
Related Links:
University of Texas Southwestern Medical Center
Latest Microbiology News
- Rapid Test Promises Faster Answers for Drug-Resistant Infections
- CRISPR-Based Technology Neutralizes Antibiotic-Resistant Bacteria
- Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
- AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
- New Test Measures How Effectively Antibiotics Kill Bacteria
- New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics
- New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
- Breakthroughs in Microbial Analysis to Enhance Disease Prediction
- Blood-Based Diagnostic Method Could Identify Pediatric LRTIs
- Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
- Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
- Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
- Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis
- 15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
- High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
Channels
Clinical Chemistry
view channel
Existing Hospital Analyzers Can Identify Fake Liquid Medical Products
Counterfeit and substandard medicines remain a serious global health threat, with World Health Organization estimates suggesting that 10.5% of medicines in low- and middle-income countries are either fake... Read more
Rapid Blood Testing Method Aids Safer Decision-Making in Drug-Related Emergencies
Acute recreational drug toxicity is a frequent reason for emergency department visits, yet clinicians rarely have access to confirmatory toxicology results in real time. Instead, treatment decisions are... Read moreMolecular Diagnostics
view channel
New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids
Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more
AI-Powered Liquid Biopsy Classifies Pediatric Brain Tumors with High Accuracy
Liquid biopsies offer a noninvasive way to study cancer by analyzing circulating tumor DNA in body fluids. However, in pediatric brain tumors, the small amount of ctDNA in cerebrospinal fluid has limited... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer
Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read moreBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read morePathology
view channel
Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more
New AI-Driven Platform Standardizes Tuberculosis Smear Microscopy Workflow
Sputum smear microscopy remains central to tuberculosis treatment monitoring and follow-up, particularly in high‑burden settings where serial testing is routine. Yet consistent, repeatable bacillary assessment... Read more
AI Tool Uses Blood Biomarkers to Predict Transplant Complications Before Symptoms Appear
Stem cell and bone marrow transplants can be lifesaving, but serious complications may arise months after patients leave the hospital. One of the most dangerous is chronic graft-versus-host disease, in... Read moreTechnology
view channel
Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms
More than 7 million Americans live with Alzheimer’s disease, and related health and long-term care costs are projected to reach nearly USD 400 billion in 2025. The disease has no cure, and symptoms often... Read more
AI-Powered Biomarker Predicts Liver Cancer Risk
Liver cancer, or hepatocellular carcinoma, causes more than 800,000 deaths worldwide each year and often goes undetected until late stages. Even after treatment, recurrence rates reach 70% to 80%, contributing... Read more
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreIndustry
view channel
QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio
QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more







